Concepedia

Menglei Zhu

MZ

Statistics

Publications

13

Citations

515

H-Index

12

Active since

1997

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Zhengzhou University

University Hospitals of Cleveland

Chinese Academy of Sciences

Menglei Zhu is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, immunology, and immunotherapy.

ORCID

Publications per year

1997–2024

13

Publications

13

Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance

Imran S. Khan, Maria L. Mouchess, Menglei Zhu et al. · The Journal of Experimental Medicine · 2014 · 131 citations · Full text

, , +17

Phenotypic stability of a cytotoxic T-cell line directed against an immunodominant epitope of human carcinoembryonic antigen.

K. Y. Tsang, Menglei Zhu, Carol Nieroda et al. · PubMed · 1997 · 71 citations

, , +17

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

Ross Firestone, Devin McAvoy, Tala Shekarkhand et al. · Blood Advances · 2023 · 49 citations · Full text

, , +17

Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma

Ross Firestone, Nicholas D. Socci, Tala Shekarkhand et al. · Blood · 2024 · 49 citations · Full text

, , +15

Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity

Pearl Bakhru, Menglei Zhu, Hsing‐Hui Wang et al. · JCI Insight · 2017 · 44 citations · Full text

, , +17

1–5 of 13